Securities notice · Vesalius Longevity Labs is not yet a reporting issuer. The proposed reverse takeover transaction is subject to regulatory and shareholder approvals. Nothing on this site constitutes an offer to sell or solicitation to buy securities.
Share structure and transaction structure.
Vesalius Longevity Labs (Canada) Inc. (“Canada”) and Vesalius Longevity Labs (SPV) Inc. (“SPV”) are completing a reverse takeover (“RTO”) with Sweet Earth Holdings Corporation, which is still undergoing CSE approval. Upon closing, the three companies will amalgamate into a single public company (the “Resulting Issuer”) whose shares will trade on the Canadian Securities Exchange (“CSE”) under the ticker symbol “VLAB”.
There has not been a closing date set yet.
Resulting Issuer Capital Table
Ticker symbolCSE: VLAB (expected at close)
Share structure — August 2026 investor deck
- Shares
- 100,828,965
- Options
- 5,850,000
- RSUs
- 2,000,000
- Warrants
- 10,434,750
- Total diluted I/O
- 119,113,715
- Cash
- US$8 million
- Debt
- N/A